Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07721415Phase 4Enrolling by invitation
A Phase 4 trial of iodine in surgical site infection (SSI), sponsored by Nimbus Therapeutics. Started Jan 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07721415.